Results: Administration of DAF significantly reduced intestinal and lung tissue damage in a dose-dependent manner (5, 25, and 50 mu g/kg). In addition, DAF treatment improved hemorrhage-induced hyperkalemia. The protective effects of DAF appear to be related to its ability to reduce tissue complement activation and deposition on affected tissues.
Conclusions: DAF treatment decreased tissue complement activation and deposition in hemorrhaged animals and attenuated
tissue damage at 200 minutes after treatment. The observed beneficial effects of DAF treatment on tissue injury after 20 minutes of severe hypotension presents an attractive model of small volume resuscitation, particularly in situations with a restrictive medical logistical footprint such as far-forward access to first responders in the battlefield Belnacasan or in remote rural or mountainous environments.”
The aim of this study was to explore
Greek problem drug users’ perceptions of the reasons that led them to quit using drugs and engage in treatment of their own volition.
Qualitative semi-structured in-depth interviews.
Two state drug agencies in Thessaloniki, Greece.
A total of 40 adult problem drug-using men and women participated in the study.
Participants were asked to reflect on their decisions to wean themselves from drugs and enter treatment.
Participants reported that their decisions centred on the re-conceptualization of the drug-using community and their membership in it, the desire to restore aspects of identities that were deemed to be selleck inhibitor spoiled, and finally memories of their drug-free selves. The importance of the distinctively Greek notion of filotimo in this discussion is highlighted.
Primarily find more in relation to filotimo (a concept that represents a complex array of virtues that regulates behaviour towards one’s family), the desire to restore one’s spoiled identity plays a pivotal role in Greek problem drug users’ decisions to cease drug use and engage in treatment.”
“Background: Treatment outcomes for antiretroviral therapy (ART) patients may vary by gender, but estimates
from current evidence may be confounded by disease stage and adherence. We investigated the gender differences in treatment response among HIV-positive patients virally suppressed within 6 months of treatment initiation.
Methods: We analyzed data from 7,354 patients initiating ART between April 2004 and April 2010 at Themba Lethu Clinic, a large urban public sector treatment facility in South Africa. We estimated the relations among gender, mortality, and mean CD4 response in HIV-infected adults virally suppressed within 6 months of treatment initiation and used inverse probability of treatment weights to correct estimates for loss to follow-up.
Results: Male patients had a 20% greater risk of death at both 24 months and 36 months of follow-up compared to females.